HCPLive Network
  • CDC Chief Says Ebola Outbreak is Worse than Feared
  • Chronic Pain Peer Exchange Video Series
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Healthcare workers in poor nations often do not have enough protective gear to keep them safe from being infected with blood-borne viruses such as Ebola and HIV, according to a study published online Aug. 8 in Tropical Medicine & International Health.
By Amy Jacob
Insulin, a peptide hormone, can protect the cells of the pancreas from acute pancreatitis – a disease for which there is currently no cure, according to a study by scientists from The University of Manchester.
By Julia Ernst, MS
Ixekizumab, a drug being evaluated for the treatment of moderate-to-severe chronic plaque psoriasis, continues to demonstrate efficacy and safety in Phase III trials.
By Adam Hochron
One of the most common treatment courses for chronic pain is comprised of prescription opioid medications. However, concerns about drug addiction and abuse oftentimes outweigh the drugs’ pain-relieving benefits.
By Katie Eder, Managing Editor
Although many physicians currently snap, store, and share clinical photographs on their smartphones, they often neglect to ask patients for permission to do so.
By Jeannette Wick
Since many patients have insulin resistance, prescribing insulin therapy for diabetes often requires trial and error.
By Rachel Lutz
Post-traumatic stress disorder and depressive symptoms may be reduced with intravenous ketamine, according to research published in JAMA Psychiatry.
By Adam Hochron
As the practice of telecare continues to gain momentum, a group of researchers conducted a study to test how effective that course of treatment is in patients with chronic illnesses.
By Jacquelyn Gray
Among couples with an HIV-positive member, a study in the Cochrane Database of Systematic Reviews (CDSR) deemed antiretroviral therapy (ART) effective at preventing HIV transmission to the HIV-negative partner.
By Adam Hochron
When a patient arrives at a hospital or other urgent care center, there are seemingly endless tests that can be undertaken to appropriately diagnose the patient. A recent study reviewed the necessity of some tests, particularly in regard to acute, nonspecific lower back pain.
Email Signup
Breaking News
GlaxoSmithKline's Arnuity approved for patients over the age of 12 as part of treatment options
Researchers from the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline will soon launch phase I clinical trials of experimental Ebola vaccines.
Physician's Money Digest
Medical research funding is critical, but many promising startups never reach clinical stages due to a lack of funds. However, the path has opened up for even the average investor.
After years of delayed gratification, most young physicians transitioning from residency or fellowship into practice want to buy a house they will be happy living in.
Product News
An investigational drug that researchers hope will reverse nerve damage in patients with multiple sclerosis (MS) has been found to be safe and well tolerated in early trials. The big question is whether it will work, researchers said.
The US Food and Drug Administration announced it will give priority review status to Amgen’s application to market ivabradine as a treatment for chronic heart failure.
Clinicians who treat patients suffering with osteoarthritis pain have a new low-dose nonsteroidal anti-inflammatory drug (NSAID) option at their disposal. Zorvolex (diclofenac) was developed to meet prevailing FDA recommendations regarding NSAID dosing and treatment duration.
One-pill regiment includes abacavir, dolutegravir and lamivudine.
Eliquis is also now indicated for reducing the risk of recurrent DVT and PE following initial therapy.